Content specific to this active ingredient… Drug Information Prescribing and patient information from leading authorities Drug Master Files Type 2 master files on file at the FDA Drug Recalls For prescription drugs containing this active ingredient Exclusivity Patent and market exclusivity data Federal Register FR search results for this API FDA Approved Labelling Information found in this drug's package inserts Research Links Chemical identification and research citations Title 21 Code of Federal Regulations FDA regulations for this API

FDA Approval Activities for this Drug… AVODART (dutasteride) soft-gelatin capsules, GlaxoSmithKline NDA 21-319/S-001 Duagen (Dutasteride) Soft gel Capsules, 0.5 mg, GlaxoSmithKline NDA 21-319 11/20/01 1/14/02 Dutasteride Indications: for the signs and symptoms of benign prostatic hyperplasia. AVODART (dutasteride) soft-gelatin capsules, GlaxoSmithKline Avodart (dutasteride) soft-gelatin capsules, GlaxoSmithKline, Labeling Revision Avodart (dutasteride) soft-gelatin capsules, GlaxoSmithKline, Efficacy Supplement with Clinical Data to Support Avodart (dutasteride) soft-gelatin capsules, GlaxoSmithKline, Efficacy Supplement with Clinical Data to Support Avodart (dutasteride) soft-gelatin capsules, GlaxoSmithKline, Supplement | Avodart (dutasteride) soft gelatin capsule, GlaxoSmithKline, Labeling Revision | Avodart (dutasteride) Soft Gelatin Capsule, GlaxoSmithKline, Labeling Revision | Avodart (dutasteride) Soft Gelatin Capsule, GlaxoSmithKline, New or Modified Indication ^ FDA's latest approval appears at the bottom of this list. ^   A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | News Feed for each API | DMF Index | Pharma Job Search | Pharma Company News © 2008 Betterchem.com